Title: Bioactivity of Ti-6Al-4V alloy implants treated with ibandronate after the formation of the nanotube TiO2 layer.
Journal: Journal of biomedical materials research. Part B, Applied biomaterials 20121101
Title: Incidence of maxillary sinusitis and oro-antral fistulae in bisphosphonate-related osteonecrosis of the jaw.
Journal: Journal of cranio-maxillo-facial surgery : official publication of the European Association for Cranio-Maxillo-Facial Surgery 20121001
Title: Six months of parathyroid Hormone (1-84) administered concurrently versus sequentially with monthly ibandronate over two years: the PTH and ibandronate combination study (PICS) randomized trial.
Journal: The Journal of clinical endocrinology and metabolism 20121001
Title: Oral bisphosphonate-related osteonecrosis of the jaws: Clinical characteristics of a series of 20 cases in Spain.
Journal: Medicina oral, patologia oral y cirugia bucal 20120901
Title: Efficacy of intravenously administered ibandronate in postmenopausal Korean women with insufficient response to orally administered bisphosphonates.
Journal: Journal of bone and mineral metabolism 20120901
Title: Bisphosphonate-related osteonecrosis of the jaw in patients with oral bisphosphonate exposure: clinical course and outcomes.
Journal: Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons 20120801
Title: Once-monthly oral ibandronate provides significant improvement in bone mineral density in postmenopausal women treated with glucocorticoids for inflammatory rheumatic diseases: a 12-month, randomized, double-blind, placebo-controlled trial.
Journal: Scandinavian journal of rheumatology 20120801
Title: Monitoring of bone turnover markers does not improve persistence with ibandronate treatment.
Journal: Joint, bone, spine : revue du rhumatisme 20120701
Title: Bisphosphonate-related osteonecrosis of the mandible secondary to postural pressure.
Journal: Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons 20120701
Title: Adherence with intravenous zoledronate and intravenous ibandronate in the United States Medicare population.
Journal: Arthritis care & research 20120701
Title: Once-monthly oral ibandronate treatment in an adolescent with recurrent fractures and inadequately low bone mass.
Journal: Journal of paediatrics and child health 20120701
Title: Efficacy of monthly oral ibandronate is sustained over 5 years: the MOBILE long-term extension study.
Journal: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20120601
Title: Long-term administration of quarterly IV ibandronate is effective and well tolerated in postmenopausal osteoporosis: 5-year data from the DIVA study long-term extension.
Journal: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20120601
Title: Gastrointestinal bleeding following intravenous ibandronate administration.
Journal: Journal of pharmacy practice 20120601
Title: Monthly ibandronate for the prevention of bone loss in patients after liver transplantation.
Journal: Transplantation proceedings 20120601
Title: Successful treatment of calcific uraemic arteriolopathy with bisphosphonates.
Journal: Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia 20120514
Title: [Simultaneous determination of alendronate, pamidronate, ibandronate and risedronate using ion chromatography with integrated pulsed amperometric detection].
Journal: Se pu = Chinese journal of chromatography 20120401
Title: Effect of dosing interval duration of intermittent ibandronate treatment on the healing process of femoral osteotomy in a rat fracture model.
Journal: Calcified tissue international 20120301
Title: Phase I clinical study to select a novel oral formulation for ibandronate containing the excipient sodium N-[8-(2-hydroxybenzoyl) amino] caprylate (SNAC).
Journal: Die Pharmazie 20120301
Title: Question: In postmenopausal women with osteoporosis is once monthly oral ibandronate (150 mg) therapy preferred to once weekly oral bisphosphonate therapy.
Journal: The Journal of the Oklahoma State Medical Association 20120301
Title: Ibandronate and calcitriol reduces fracture risk, reverses bone loss, and normalizes bone turnover after LTX.
Journal: Transplantation 20120215
Title: Influence of bisphosphonates on the osteoblast RANKL and OPG gene expression in vitro.
Journal: Clinical oral investigations 20120201
Title: Counting touching cell nuclei using fast ellipse detection to assess in vitro cell characteristics: a feasibility study.
Journal: Clinical oral investigations 20120201
Title: The influence of bisphosphonates on viability, migration, and apoptosis of human oral keratinocytes--in vitro study.
Journal: Clinical oral investigations 20120201
Title: Bisphosphonate-related osteonecrosis of jaws in 3 osteoporotic patients with history of oral bisphosphonate use treated with single yearly zoledronic acid infusion.
Journal: Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons 20120201
Title: [Pelvic pain in the athlete: not always that simple...].
Journal: Revue medicale suisse 20120125
Title: Effect of monthly ibandronate on hip structural geometry in men with low bone density.
Journal: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20120101
Title: Impact of oral ibandronate 150 mg once monthly on bone structure and density in post-menopausal osteoporosis or osteopenia derived from in vivo μCT.
Journal: Bone 20120101
Title: Possible role of oral ibandronate administration in Osteonecrosis of the Jaw: a case report.
Journal: International journal of immunopathology and pharmacology 20120101
Title: Pathogenesis and bisphosphonate treatment of skeletal events and bone pain in metastatic cancer: focus on ibandronate.
Journal: Onkologie 20120101
Title: Phase II study of loading-dose ibandronate treatment in patients with breast cancer and bone metastases suffering from moderate to severe pain.
Journal: Onkologie 20120101
Title: Impact of long-term cinacalcet, ibandronate or teriparatide therapy on bone mineral density of hemodialysis patients: a pilot study.
Journal: American journal of nephrology 20120101
Title: Bisphosphonates for osteoporosis in primary biliary cirrhosis.
Journal: The Cochrane database of systematic reviews 20111207
Title: Daily or monthly ibandronate prevents or restores deteriorations of bone mass, architecture, biomechanical properties and markers of bone turnover in androgen-deficient aged rats.
Journal: The aging male : the official journal of the International Society for the Study of the Aging Male 20111201
Title: Zoledronate, ibandronate and clodronate enhance osteoblast differentiation in a dose dependent manner--a quantitative in vitro gene expression analysis of Dlx5, Runx2, OCN, MSX1 and MSX2.
Journal: Journal of cranio-maxillo-facial surgery : official publication of the European Association for Cranio-Maxillo-Facial Surgery 20111201
Title: Renal safety of ibandronate 6 mg infused over 15 min versus 60 min in breast cancer patients with bone metastases: a randomized open-label equivalence trial.
Journal: Breast (Edinburgh, Scotland) 20111201
Title: Effects of intravenous ibandronate injection on renal function in women with postmenopausal osteoporosis at high risk for renal disease--the DIVINE study.
Journal: Bone 20111201
Title: Monthly or weekly bisphosphonate? Evaluation of satisfaction in patients with postmenopausal osteoporosis using OPSAT-Q questionnaire during the BOOSTER study in Croatia.
Journal: Clinical rheumatology 20111201
Title: Integrated model for denosumab and ibandronate pharmacodynamics in postmenopausal women.
Journal: Biopharmaceutics & drug disposition 20111101
Title: The GISS trial: a phase II prevention trial of screening plus goserelin, ibandronate, versus screening alone in premenopausal women at increased risk of breast cancer.
Journal: Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 20111001
Title: Analysis of the comparative effectiveness of 3 oral bisphosphonates in a large managed care organization: adherence, fracture rates, and all-cause cost.
Journal: Journal of managed care pharmacy : JMCP 20111001
Title: Effect of ibandronate on disseminated tumor cells in the bone marrow of patients with primary breast cancer: a pilot study.
Journal: Anticancer research 20111001
Title: Benefit of infusions with ibandronate treatment in children with osteogenesis imperfecta.
Journal: Chinese medical journal 20111001
Title: Parenteral bisphosphonates for osteoporosis in patients with primary biliary cirrhosis.
Journal: American journal of therapeutics 20110901
Title: A comparative study of intravenous ibandronate and pamindronate in patients with bone metastases from breast or lung cancer: effect on metastatic bone pain.
Journal: American journal of therapeutics 20110901
Title: Efficacy and safety of monthly 150 mg oral ibandronate in women with postmenopausal osteoporosis: a systematic review and meta-analysis of randomized controlled trials.
Journal: The Korean journal of internal medicine 20110901
Title: Administration of sodium ibandronate in the treatment of complicated giant cell tumor of the spine.
Journal: Spine 20110801
Title: Non-surgical management of stage 3 biphosphonate-related oroantral fistula.
Journal: The British journal of oral & maxillofacial surgery 20110701
Title: Effect of bisphosphonates on anodized and heat-treated titanium surfaces: an animal experimental study.
Journal: Journal of periodontology 20110701
Title: [Assessment of volumetric bone mineral density and geometry for hip with clinical CT device].
Journal: Clinical calcium 20110701
Title: Effects of intravenous zoledronic acid and oral ibandronate on early changes in markers of bone turnover in patients with bone metastases from non-small cell lung cancer.
Journal: International journal of clinical oncology 20110601
Title: Intravenous bisphosphonates for post-menopausal osteoporosis: adherence to a network guideline.
Journal: Journal of clinical pharmacy and therapeutics 20110601
Title: Intravenous ibandronate or sodium-fluoride--a 3.5 years study on bone density and fractures in Crohn's disease patients with osteoporosis.
Journal: Journal of gastrointestinal and liver diseases : JGLD 20110601
Title: Commentary on an article by Jacob S. Vandermeer et al.: 'Local administration of ibandronate and bone morphogenetic protein-2 after ischemic osteonecrosis of the immature femoral head. A combined therapy that stimulates bone formation and decreases femoral head deformity'.
Journal: The Journal of bone and joint surgery. American volume 20110518
Title: Local administration of ibandronate and bone morphogenetic protein-2 after ischemic osteonecrosis of the immature femoral head: a combined therapy that stimulates bone formation and decreases femoral head deformity.
Journal: The Journal of bone and joint surgery. American volume 20110518
Title: Ibandronate does not reduce the anabolic effects of PTH in ovariectomized rat tibiae: a microarchitectural and mechanical study.
Journal: Bone 20110501
Title: Low-magnitude high-frequency vibration (LMHFV) enhances bone remodeling in osteoporotic rat femoral fracture healing.
Journal: Journal of orthopaedic research : official publication of the Orthopaedic Research Society 20110501
Title: Efficacy, side effects and route of administration are more important than frequency of dosing of anti-osteoporosis treatments in determining patient adherence: a critical review of published articles from 1970 to 2009.
Journal: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20110301
Title: Bisphosphonates affect migration ability and cell viability of HUVEC, fibroblasts and osteoblasts in vitro.
Journal: Oral diseases 20110301
Title: Bone mineral disease in children after renal transplantation in steroid-free and steroid-treated patients--a prospective study.
Journal: Pediatric transplantation 20110301
Title: Treatment of lumbar pars interarticularis stress injuries in athletes with intravenous bisphosphonates: five case studies.
Journal: Clinical journal of sport medicine : official journal of the Canadian Academy of Sport Medicine 20110301
Title: The treatment of symptomatic osteoporotic spinal compression fractures.
Journal: The Journal of the American Academy of Orthopaedic Surgeons 20110301
Title: Stability indicating ion chromatography method for the simultaneous determination of ibandronate sodium drug substance and its impurities.
Journal: Journal of pharmaceutical and biomedical analysis 20110220
Title: Osteonecrosis of the jaw and the role of macrophages.
Journal: Journal of the National Cancer Institute 20110202
Title: Bisphosphonates: restrictions for vasculogenesis and angiogenesis: inhibition of cell function of endothelial progenitor cells and mature endothelial cells in vitro.
Journal: Clinical oral investigations 20110201
Title: Bisphosphonates inhibit phosphorylation of signal transducer and activator of transcription 3 and expression of suppressor of cytokine signaling 3: implications for their effects on innate immune function and osteoclastogenesis.
Journal: Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics 20110201
Title: Bones and Crohn's: no benefit of adding sodium fluoride or ibandronate to calcium and vitamin D.
Journal: World journal of gastroenterology 20110121
Title: Ibandronate promotes osteogenic differentiation of periodontal ligament stem cells by regulating the expression of microRNAs.
Journal: Biochemical and biophysical research communications 20110107
Title: Differential effects of ibandronate, docetaxel and farnesol treatment alone and in combination on the growth of prostate cancer cell lines.
Journal: Acta oncologica (Stockholm, Sweden) 20110101
Title: Ibandronate affects bone growth and mineralization in rats with normal and reduced renal function.
Journal: Pediatric nephrology (Berlin, Germany) 20110101
Title: [Ibandronate].
Journal: Clinical calcium 20110101
Title: When do bisphosphonates make the most sense?
Journal: The Journal of family practice 20110101
Title: The role of i.v. ibandronate administration in osteoporosis therapy.
Journal: Endokrynologia Polska 20110101
Title: Adverse cutaneous drug reactions to ibandronate.
Journal: European journal of dermatology : EJD 20110101
Title: [The role of i.v. ibandronate administration in osteoporosis therapy].
Journal: Endokrynologia Polska 20110101
Title: [Osteonecrosis of the jaw associated with oral treatment with ibandronate].
Journal: Anales del sistema sanitario de Navarra 20110101
Title: Drug-drug interaction study between a novel oral ibandronate formulation and metformin.
Journal: Arzneimittel-Forschung 20110101
Title: Prospective clinical study of once monthly ibandronate in the treatment of osteoporosis and prevention of fractures in postmenopausal women: ORPHEUM Study.
Journal: Srpski arhiv za celokupno lekarstvo 20110101
Title: Adherence to bisphosphonate therapy in postmenopausal osteoporotic women.
Journal: Folia medica 20110101
Title: Preparation and properties of new co-crystals of ibandronate with gluco- or galactopyranoside derivatives.
Journal: Molecules (Basel, Switzerland) 20101208
Title: Outcome of patients with early breast cancer receiving nitrogen-containing bisphosphonates: a comparative analysis from the Metropolitan Detroit Cancer Surveillance System.
Journal: Clinical breast cancer 20101201
Title: Osteonecrosis of the jaw: effect of bisphosphonate type, local concentration, and acidic milieu on the pathomechanism.
Journal: Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons 20101101
Title: Bilateral simultaneous femoral diaphyseal fractures in a patient with long-term ibandronate use.
Journal: Orthopedics 20101011
Title: Bone pain reduction in patients with metastatic breast cancer treated with ibandronate-results from a post-marketing surveillance study.
Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 20101001
Title: Enzyme-linked immunosorbent serum assays (ELISAs) for rat and human N-terminal pro-peptide of collagen type I (PINP)--assessment of corresponding epitopes.
Journal: Clinical biochemistry 20101001
Title: Increases in hip and spine bone mineral density are predictive for vertebral antifracture efficacy with ibandronate.
Journal: Calcified tissue international 20101001
Title: The increased expression of receptor activator of nuclear-kappaB ligand (RANKL) of multiple myeloma bone marrow stromal cells is inhibited by the bisphosphonate ibandronate.
Journal: Journal of cellular biochemistry 20100901
Title: Successful treatment of SAPHO syndrome with ibandronate.
Journal: Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases 20100801
Title: Treatment of osteoporosis after liver transplantation with ibandronate.
Journal: Transplant international : official journal of the European Society for Organ Transplantation 20100701
Title: Longitudinal change in clinical fracture incidence after initiation of bisphosphonates.
Journal: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20100601
Title: Regional distribution of spine and hip QCT BMD responses after one year of once-monthly ibandronate in postmenopausal osteoporosis.
Journal: Bone 20100601
Title: Postmenopausal osteoporosis: another approach to management.
Journal: The Journal of family practice 20100601
Title: [Monthly ibandronate attachment to Mexican and Chilean women with osteoporosis, with or without a biofeedback strategy].
Journal: Ginecologia y obstetricia de Mexico 20100601
Title: An in vitro assay to measure targeted drug delivery to bone mineral.
Journal: ChemMedChem 20100503
Title: Infusion of ibandronate once every 3 months effectively decreases bone resorption markers and increases bone mineral density in Chinese postmenopausal osteoporotic women: a 1-year study.
Journal: Journal of bone and mineral metabolism 20100501
Title: Ibandronate does not increase risk of atrial fibrillation in analysis of pivotal clinical trials.
Journal: International journal of clinical practice 20100501
Title: How patients' lack of knowledge about oral bisphosphonates can interfere with medical and dental care.
Journal: Journal of the American Dental Association (1939) 20100501
Title: Efficacy and safety of monthly ibandronate in men with low bone density.
Journal: Bone 20100401
Title: Synthesis and preliminary pharmacological characterisation of a new class of nitrogen-containing bisphosphonates (N-BPs).
Journal: Bioorganic & medicinal chemistry 20100401
Title: Effects of intermittent intravenous ibandronate injections on bone quality and micro-architecture in women with postmenopausal osteoporosis: the DIVA study.
Journal: Bone 20100301
Title: Risk reduction of non-vertebral fractures with intravenous ibandronate: post-hoc analysis from DIVA.
Journal: Current medical research and opinion 20100301
Title: Renal function changes and NHS resource use in breast cancer patients with metastatic bone disease treated with IV zoledronic acid or oral ibandronic acid: a four-centre non-interventional study.
Journal: Journal of medical economics 20100301
Title: Prevalence of osteonecrosis of the jaw in patients with oral bisphosphonate exposure.
Journal: Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons 20100201
Title: Oral ibandronate in metastatic bone breast cancer: the Florence University experience and a review of the literature.
Journal: Journal of chemotherapy (Florence, Italy) 20100201
Title: Adherence to monthly and weekly oral bisphosphonates in women with osteoporosis.
Journal: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20100101
Title: Management of symptomatic bone metastases from breast cancer with concomitant use of external radiotherapy and ibandronate: results of a prospective, pilot study.
Journal: The breast journal 20100101
Title: The utility of changes in serum levels of C-terminal telopeptide of type I collagen in predicting patient response to oral monthly ibandronate therapy.
Journal: Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry 20100101
Title: Efficacy and safety of once monthly ibandronate treatment in patients with reduced bone mineral density--ESTHER study.
Journal: Srpski arhiv za celokupno lekarstvo 20100101
Title: Renal toxicity in patients with multiple myeloma receiving zoledronic acid vs. ibandronate: a retrospective medical records review.
Journal: Journal of cancer research and therapeutics 20100101
Title: Alterations in osteoclast function and phenotype induced by different inhibitors of bone resorption--implications for osteoclast quality.
Journal: BMC musculoskeletal disorders 20100101
Title: Challenges in clinical patient management.
Journal: Cancer investigation 20100101
Title: Long-term renal safety profile of ibandronate 6 mg infused over 15 minutes.
Journal: Onkologie 20100101
Title: Health-related quality of life among patients with postmenopausal osteoporosis treated with weekly and monthly bisphosphonates.
Journal: Endocrine research 20100101
Title: Ibandronate increases cortical bone density in patients with systemic lupus erythematosus on long-term glucocorticoid.
Journal: Arthritis research & therapy 20100101
Title: Bisphosphonates in calcific aortic stenosis: association with slower progression in mild disease--a pilot retrospective study.
Journal: Cardiology 20100101
Title: The efficiency of Bonviva (Ibadronate) in women with pre-post menopause.
Journal: Medicinski arhiv 20100101
Title: Osteonecrosis of the jaw in patients with multiple myeloma treated with bisphosphanates.
Journal: Prilozi 20100101
Title: Apoptosis-mediated cytotoxic effects of ibandronic acid on hormone- and drug-refractory prostate cancer cells and human breast cancer cells.
Journal: The Journal of international medical research 20100101
Title: Metronomic administration of ibandronate and its anti-angiogenic effects in vitro.
Journal: Microvascular research 20091201
Title: Update on monthly oral bisphosphonate therapy for the treatment of osteoporosis: focus on ibandronate 150 mg and risedronate 150 mg.
Journal: Current medical research and opinion 20091201
Title: Review of osteoporosis pharmacotherapy for geriatric patients.
Journal: The American journal of geriatric pharmacotherapy 20091201
Title: Longitudinal cohort study of risk factors in cancer patients of bisphosphonate-related osteonecrosis of the jaw.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20091110
Title: Efficacy of ibandronate for the treatment of skeletal events in patients with metastatic breast cancer.
Journal: European journal of cancer care 20091101
Title: Comparison of monthly ibandronate versus weekly risedronate in preference, convenience, and bone turnover markers in Korean postmenopausal osteoporotic women.
Journal: Calcified tissue international 20091101
Title: A retrospective clinical and radiographic study on healing of periradicular lesions in patients taking oral bisphosphonates.
Journal: Journal of endodontics 20091101
Title: High-throughput HPLC-MS/MS method to determine ibandronate in human plasma for pharmacokinetic applications.
Journal: Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20091001
Title: [Anti-fracture efficacy of intravenous ibandronate: how to translate epidemiological studies into daily clinical practice].
Journal: Revue medicale de Liege 20091001
Title: Monthly ibandronate suppresses serum CTX-I within 3 days and maintains a monthly fluctuating pattern of suppression.
Journal: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20090901
Title: Ibandronate reduces endogenous reactive oxygen species levels in cultured prostate cancer and endothelial cells.
Journal: Microvascular research 20090901
Title: Ibandronate: a review of its vertebral and nonvertebral antifracture efficacy.
Journal: Women's health (London, England) 20090901
Title: Tolerability of dose escalation of ibandronate in patients with multiple myeloma and end-stage renal disease: a case series.
Journal: Onkologie 20090901
Title: [Emergencies in hematology and oncology].
Journal: Deutsche medizinische Wochenschrift (1946) 20090901
Title: [Diagnosis and treatment of bone marrow edema syndrome of the hip and differential diagnosis from avascular necrosis of femoral head].
Journal: Zhongguo gu shang = China journal of orthopaedics and traumatology 20090901
Title: Safety and antisorptive power of Ibandronate applied in the real-life setting.
Journal: Journal of the Medical Association of Thailand = Chotmaihet thangphaet 20090901
Title: Impact of bone marker feedback on adherence to once monthly ibandronate for osteoporosis among Asian postmenopausal women.
Journal: International journal of rheumatic diseases 20090901
Title: Weekly versus monthly drug regimens: 1-year compliance and persistence with bisphosphonate therapy.
Journal: Current medical research and opinion 20090801
Title: Pricey osteoporosis remedy doesn't beat older drugs.
Journal: Consumer reports 20090801
Title: Ibandronate prevents bone loss and reduces vertebral fracture risk in male cardiac transplant patients: a randomized double-blind, placebo-controlled trial.
Journal: Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20090701
Title: Patient satisfaction in postmenopausal women treated with a weekly bisphosphonate transitioned to once-monthly ibandronate.
Journal: Journal of women's health (2002) 20090701
Title: Once-monthly oral ibandronate in postmenopausal osteoporosis: translation and updated review.
Journal: Clinical therapeutics 20090701
Title: Risk of renal impairment after treatment with ibandronate versus zoledronic acid: a retrospective medical records review.
Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 20090601
Title: Risk of fracture in women treated with monthly oral ibandronate or weekly bisphosphonates: the eValuation of IBandronate Efficacy (VIBE) database fracture study.
Journal: Bone 20090501
Title: Improved GI tolerability with monthly ibandronate in women previously using weekly bisphosphonates.
Journal: Southern medical journal 20090501
Title: [Drugs under development for osteoporosis ].
Journal: Nihon rinsho. Japanese journal of clinical medicine 20090501
Title: Risk of severe gastrointestinal events in women treated with monthly ibandronate or weekly alendronate and risedronate.
Journal: The Annals of pharmacotherapy 20090401
Title: Efficacy and tolerability of once-monthly oral ibandronate (150 mg) and once-weekly oral alendronate (70 mg): additional results from the Monthly Oral Therapy With Ibandronate For Osteoporosis Intervention (MOTION) study.
Journal: Clinical therapeutics 20090401
Title: Efficacy and safety of monthly oral ibandronate in the prevention of postmenopausal bone loss.
Journal: Bone 20090301
Title: Preference for weekly and monthly bisphosphonates among patients with postmenopausal osteoporosis: results from the Croatian PROMO Study.
Journal: Clinical rheumatology 20090301
Title: Ibandronate dose response is associated with increases in bone mineral density and reductions in clinical fractures: results of a meta-analysis.
Journal: Bone 20090301
Title: The effect of surface immobilized bisphosphonates on the fixation of hydroxyapatite-coated titanium implants in ovariectomized rats.
Journal: Biomaterials 20090301
Title: Ibandronate for the prevention of nonvertebral fractures: a pooled analysis of individual patient data.
Journal: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20090201
Title: Plain film and CBCT findings in a case of bisphosphonate-related osteonecrosis of the jaw.
Journal: Quintessence international (Berlin, Germany : 1985) 20090201
Title: Efficacy of bisphosphonates in reducing fracture risk in postmenopausal osteoporosis.
Journal: The American journal of medicine 20090201
Title: Higher incidence of Osteonecrosis of the Jaw (ONJ) in patients with metastatic castration resistant prostate cancer treated with anti-angiogenic agents.
Journal: Cancer investigation 20090201
Title: Once-monthly oral ibandronate improves biomechanical determinants of bone strength in women with postmenopausal osteoporosis.
Journal: The Journal of clinical endocrinology and metabolism 20090101
Title: Oral ibandronate preserves trabecular microarchitecture: micro-computed tomography findings from the oral iBandronate Osteoporosis vertebral fracture trial in North America and Europe study.
Journal: Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry 20090101
Title: [New development in bisphosphonate treatment. Characteristics and effectiveness of intermittent bisphophonates].
Journal: Clinical calcium 20090101
Title: Identification of secondary targets of N-containing bisphosphonates in mammalian cells via parallel competition analysis of the barcoded yeast deletion collection.
Journal: Genome biology 20090101
Title: Gastrointestinal tolerability with ibandronate after previous weekly bisphosphonate treatment.
Journal: Clinical interventions in aging 20090101
Title: Is there a role for ibandronate in the treatment of prostate cancer patients with bony metastases?
Journal: Acta oncologica (Stockholm, Sweden) 20090101
Title: Dendritic multishell architectures for drug and dye transport.
Journal: Journal of controlled release : official journal of the Controlled Release Society 20081218
Title: Oral versus intravenous ibandronic acid: a comparison of treatment options for metastatic bone disease.
Journal: Journal of cancer research and clinical oncology 20081201
Title: Clinical and radiologic response in patients with bone metastases managed with combined radiotherapy and bisphosphonates.
Journal: Journal of surgical oncology 20081201
Title: Managing neoplastic bone disease with ibandronic acid: a preclinical and clinical data update.
Journal: Expert opinion on pharmacotherapy 20081201
Title: [Bisphosphonates for osseus invasion caused by bronchial carcinoma].
Journal: Deutsche medizinische Wochenschrift (1946) 20081101
Title: Ibandronate: is there an effect on nonvertebral fractures?
Journal: Clinical rheumatology 20081001
Title: An open-label pilot trial of ibandronate for complex regional pain syndrome.
Journal: The Clinical journal of pain 20081001
Title: Prevention of anastrozole-induced bone loss with monthly oral ibandronate during adjuvant aromatase inhibitor therapy for breast cancer.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research 20081001
Title: [Ibandronate in the treatment of postmenopausal osteoporosis].
Journal: Lege artis medicinae : uj magyar orvosi hirmondo 20081001
Title: Intravenous ibandronate rapidly reduces pain, neurochemical indices of central sensitization, tumor burden, and skeletal destruction in a mouse model of bone cancer.
Journal: Journal of pain and symptom management 20080901
Title: Acute phase reaction with intravenous ibandronate.
Journal: The American journal of medicine 20080901
Title: Nonvertebral fracture risk reduction with nitrogen-containing bisphosphonates.
Journal: Current osteoporosis reports 20080901
Title: Therapies for treatment of osteoporosis in US women: cost-effectiveness and budget impact considerations.
Journal: The American journal of managed care 20080901
Title: [Update on treatment of postmenopausal osteoporosis].
Journal: Revue medicale de Bruxelles 20080901
Title: Monthly oral ibandronate is effective and well tolerated after 3 years: the MOBILE long-term extension.
Journal: Clinical rheumatology 20080801
Title: [Daily practice using the guidelines for prevention and treatment of osteoporosis. Evolution of bisphosphonate therapy. Intravenous injection].
Journal: Clinical calcium 20080801
Title: Renal safety profiles of ibandronate 6 mg infused over 15 and 60 min: a randomized, open-label study.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology 20080701
Title: Identification of novel bone-specific molecular targets of binge alcohol and ibandronate by transcriptome analysis.
Journal: Alcoholism, clinical and experimental research 20080701
Title: Oral osteonecrosis associated with the use of ibandronate: report of a case and clinical implications.
Journal: Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics 20080701
Title: Ibandronate in profile: drug characteristics and clinical efficacy.
Journal: Expert opinion on drug metabolism & toxicology 20080701
Title: Preclinical evidence for nitrogen-containing bisphosphonate inhibition of farnesyl diphosphate (FPP) synthase in the kidney: implications for renal safety.
Journal: Toxicology in vitro : an international journal published in association with BIBRA 20080601
Title: Changes in bone remodelling and antifracture efficacy of intermittent bisphosphonate therapy: implications from clinical studies with ibandronate.
Journal: Postgraduate medical journal 20080601
Title: Treatment preference for monthly oral ibandronate and weekly oral alendronate in women with postmenopausal osteoporosis: A randomized, crossover study (BALTO II).
Journal: Joint, bone, spine : revue du rhumatisme 20080501
Title: Ibandronate in benign bone disease.
Journal: Reviews on recent clinical trials 20080501
Title: Quarterly intravenous ibandronate for postmenopausal osteoporosis.
Journal: Women's health (London, England) 20080501
Title: Effects of the bisphosphonate ibandronate on hyperalgesia, substance P, and cytokine levels in a rat model of persistent inflammatory pain.
Journal: European journal of pain (London, England) 20080401
Title: Adherence to and gastrointestinal tolerability of monthly oral or quarterly intravenous ibandronate therapy in women with previous intolerance to oral bisphosphonates: a 12-month, open-label, prospective evaluation.
Journal: Clinical therapeutics 20080401
Title: A Phase II trial evaluating the palliative benefit of second-line oral ibandronate in breast cancer patients with either a skeletal related event (SRE) or progressive bone metastases (BM) despite standard bisphosphonate (BP) therapy.
Journal: Breast cancer research and treatment 20080301
Title: Bone turnover and bone collagen maturation in osteoporosis: effects of antiresorptive therapies.
Journal: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20080301
Title: Cost-effectiveness of a fixed dose combination of alendronate and cholecalciferol in the treatment and prevention of osteoporosis in the United Kingdom and The Netherlands.
Journal: Current medical research and opinion 20080301
Title: Efficacy and tolerability of intravenous ibandronate injections in postmenopausal osteoporosis: 2-year results from the DIVA study.
Journal: The Journal of rheumatology 20080301
Title: [Osteonecrosis of the jaw developing during bisphosphonate treatment].
Journal: Magyar onkologia 20080301
Title: Reply to the article 'oral ibandronate is as active as intravenous zoledronic acid for reducing bone turnover markers in women with breast cancer and bone metastases' by J.-J. Body et al. (Ann Oncol 2007; 18: 1165-1171).
Journal: Annals of oncology : official journal of the European Society for Medical Oncology 20080201
Title: [Prescription of bisphosphonates in prostate cancer].
Journal: Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie 20080201
Title: Once-monthly oral ibandronate compared with weekly oral alendronate in postmenopausal osteoporosis: results from the head-to-head MOTION study.
Journal: Current medical research and opinion 20080101
Title: Ibandronate and the risk of non-vertebral and clinical fractures in women with postmenopausal osteoporosis: results of a meta-analysis of phase III studies.
Journal: Current medical research and opinion 20080101
Title: Vertebral fracture diagnosis in the multinational BONE study of oral ibandronate: quality management in radiology.
Journal: Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry 20080101
Title: Extracellular calcium increases bisphosphonate-induced growth inhibition of breast cancer cells.
Journal: Breast cancer research : BCR 20080101
Title: Zoledronic acid: a pharmacoeconomic review of its use in the management of bone metastases.
Journal: PharmacoEconomics 20080101
Title: Cost effectiveness of ibandronate for the prevention of fractures in inflammatory bowel disease-related osteoporosis: cost-utility analysis using a Markov model.
Journal: PharmacoEconomics 20080101
Title: [Cost-effectiveness of oral ibandronate, i.v. zoledronic acid and i.v. generic pamidronate in the management of metastatic bone disease in breast cancer patients: two parallel studies].
Journal: Recenti progressi in medicina 20080101
Title: Rapid suppression of bone resorption marker levels with ibandronate therapy in a bisphosphonate-naïve population.
Journal: Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry 20080101
Title: Cost-effectiveness of oral clodronate compared with oral ibandronate, intravenous zoledronate or intravenous pamidronate in breast cancer patients.
Journal: The Journal of international medical research 20080101
Title: Renal toxicity following zoledronic acid reversed with ibandronate in a prostate cancer patient with bone metastases.
Journal: Urologia internationalis 20080101
Title: Ibandronate uptake in the jaw is similar to long bones and vertebrae in the rat.
Journal: Journal of bone and mineral metabolism 20080101
Title: Treatment of reduced bone density with ibandronate in dialysis patients.
Journal: Journal of nephrology 20080101
Title: Preclinical and clinical efficacy of the bisphosphonate ibandronate in cancer treatment.
Journal: Current clinical pharmacology 20080101
Title: Osteonecrosis of the jaw in a patient treated with ibandronate.
Journal: Journal of B.U.ON. : official journal of the Balkan Union of Oncology 20080101
Title: [Hypercalcaemic crisis and acute renal failure due to primary hyperparathyroidism].
Journal: Deutsche medizinische Wochenschrift (1946) 20080101
Title: Ibandronate: a review of its use in the management of postmenopausal osteoporosis.
Journal: Drugs 20080101
Title: Renal tolerability of intermittent intravenous ibandronate treatment for patients with postmenopausal osteoporosis: a review.
Journal: Clinical and experimental rheumatology 20080101
Title: Metastatic ductal eccrine adenocarcinoma masquerading as an invasive ductal carcinoma of the male breast.
Journal: Journal of cutaneous pathology 20071201
Title: Evidence based medicine and effective interventions of pharmacological therapy for the prevention of osteoporotic fractures.
Journal: Minerva endocrinologica 20071201
Title: Local peroperative treatment with a bisphosphonate improves the fixation of total knee prostheses: a randomized, double-blind radiostereometric study of 50 patients.
Journal: Acta orthopaedica 20071201
Title: Linköping University Medical Dissertation No. 1033. Following the mevalonate pathway to bone heal alley.
Journal: Acta orthopaedica. Supplementum 20071201
Title: [New bone density conservation agents for osteoporosis under research and development: Ibandronate].
Journal: Nihon rinsho. Japanese journal of clinical medicine 20071128
Title: Ibandronate is effective in preventing skeletal events in patients with bone metastases from colorectal cancer.
Journal: European journal of cancer care 20071101
Title: Progression of efficacy with ibandronate: a paradigm for the development of new bisphosphonates.
Journal: Annals of the New York Academy of Sciences 20071101
Title: Vitamin D and ibandronate prevent cancellous bone loss associated with binge alcohol treatment in male rats.
Journal: Bone 20071001
Title: Osteoporosis: non-hormonal treatment.
Journal: Climacteric : the journal of the International Menopause Society 20071001
Title: [The benefit from ibandronate in the treatment of postmenopausal osteoporosis].
Journal: Vnitrni lekarstvi 20071001
Title: Application of metabonomics in a comparative profiling study reveals N-acetylfelinine excretion as a biomarker for inhibition of the farnesyl pathway by bisphosphonates.
Journal: Chemical research in toxicology 20070901
Title: Osteoporosis medication profile preference: results from the PREFER-US study.
Journal: Health expectations : an international journal of public participation in health care and health policy 20070901
Title: [Adjuvant therapy of locally advanced prostate carcinoma with ibandronate].
Journal: Der Urologe. Ausg. A 20070901
Title: Renal safety and pharmacokinetics of ibandronate in multiple myeloma patients with or without impaired renal function.
Journal: Journal of clinical pharmacology 20070801
Title: Oral bisphosphonate associated osteonecrosis of the jaws: three case reports.
Journal: British dental journal 20070728
Title: Changes in bone remodelling and antifracture efficacy of intermittent bisphosphonate therapy: implications from clinical studies with ibandronate.
Journal: Annals of the rheumatic diseases 20070701
Title: Oral ibandronate is as active as intravenous zoledronic acid for reducing bone turnover markers in women with breast cancer and bone metastases.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology 20070701
Title: New and emerging treatments for osteoporosis.
Journal: Current opinion in rheumatology 20070701
Title: Pharmacological treatment of osteoporosis for people over 70.
Journal: Aging clinical and experimental research 20070601
Title: Validation of a capillary electrophoresis method for the analysis of ibandronate related impurities.
Journal: Journal of pharmaceutical and biomedical analysis 20070509
Title: Bisphosphonates. A cornerstone of osteoporosis treatment.
Journal: Mayo Clinic women's healthsource 20070501
Title: [Nurse's role in the home management of patients with breast cancer and bone metastases].
Journal: Soins; la revue de reference infirmiere 20070501
Title: Ibandronate treatment reverses glucocorticoid-induced loss of bone mineral density and strength in minipigs.
Journal: Bone 20070301
Title: Use of intravenous bisphosphonates in osteoporosis.
Journal: Current osteoporosis reports 20070301
Title: Prevention and treatment of glucocorticoid-induced osteoporosis.
Journal: Current osteoporosis reports 20070301
Title: Quarterly intravenous injection of ibandronate to treat osteoporosis in postmenopausal women.
Journal: Clinical interventions in aging 20070301
Title: Differential effects of bisphosphonates on breast cancer cell lines.
Journal: Cancer letters 20070208
Title: Effects of ibandronate on bone quality: preclinical studies.
Journal: Bone 20070201
Title: Inhibition of bone resorption, rather than direct cytotoxicity, mediates the anti-tumour actions of ibandronate and osteoprotegerin in a murine model of breast cancer bone metastasis.
Journal: Bone 20070201
Title: Drug approvals.
Journal: The Nurse practitioner 20070201
Title: Combination ibandronate and radiotherapy for the treatment of bone metastases: clinical evaluation and radiologic assessment.
Journal: International journal of radiation oncology, biology, physics 20070101
Title: Retention, distribution, and effects of intraosseously administered ibandronate in the infarcted femoral head.
Journal: Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20070101
Title: [Therapeutic agents for disorders of bone and calcium metabolism: Ibandronate].
Journal: Clinical calcium 20070101
Title: The bisphosphonate ibandronate accelerates osseointegration of hydroxyapatite-coated cementless implants in an animal model.
Journal: Journal of orthopaedic science : official journal of the Japanese Orthopaedic Association 20070101
Title: Preventative ibandronate treatment has the most beneficial effect on the microstructure of bone in experimental tumor osteolysis.
Journal: Journal of bone and mineral metabolism 20070101
Title: Clinical usefulness of bisphosphonates in oncology: treatment of bone metastases, antitumoral activity and effect on bone resorption markers.
Journal: The International journal of biological markers 20070101
Title: A novel study investigating the therapeutic outcome of patients with lytic, mixed and sclerotic bone metastases treated with combined radiotherapy and ibandronate.
Journal: Clinical & experimental metastasis 20070101
Title: Safety considerations with bisphosphonates for the treatment of osteoporosis.
Journal: Drug safety 20070101
Title: A review of bone pain relief with ibandronate and other bisphosphonates in disorders of increased bone turnover.
Journal: Clinical and experimental rheumatology 20070101
Title: [Does ibandronate (Bonviva) have an impact on non-vertebral fractures?].
Journal: Reumatizam 20070101
Title: Population pharmacokinetics of ibandronate in Caucasian and Japanese healthy males and postmenopausal females.
Journal: International journal of clinical pharmacology and therapeutics 20061201
Title: Patient preference and adherence: comparative US studies between two bisphosphonates, weekly risedronate and monthly ibandronate.
Journal: Current medical research and opinion 20061201
Title: Bisphosphonates.
Journal: Annals of the New York Academy of Sciences 20061201
Title: Compliance with treatment for osteoporosis.
Journal: Lancet (London, England) 20061111
Title: Artery calcification in uremic rats is increased by a low protein diet and prevented by treatment with ibandronate.
Journal: Kidney international 20061101
Title: Bisphosphonates prevent experimental vascular calcification: Treat the bone to cure the vessels?
Journal: Kidney international 20061101
Title: [Ibandronate (Bonviva) in the treatment of postmenopausal osteoporosis].
Journal: Revue medicale de Liege 20061101
Title: Ibandronate (boniva) offers new options for osteoporosis.
Journal: The Nurse practitioner 20061001
Title: Clinical utility of a pharmacostatistical model for ibandronate in postmenopausal osteoporosis.
Journal: Current drug metabolism 20061001
Title: Parathyromatosis and the challenge of treatment.
Journal: American journal of kidney diseases : the official journal of the National Kidney Foundation 20060901
Title: [DVO guideline 2006. What changes have there been in the diagnosis, prevention and treatment of osteoporosis?].
Journal: Zeitschrift fur Rheumatologie 20060901
Title: Treatment persistence with once-monthly ibandronate and patient support vs. once-weekly alendronate: results from the PERSIST study.
Journal: International journal of clinical practice 20060801
Title: Rinsing morcellised bone grafts with bisphosphonate solution prevents their resorption. A prospective randomised double-blinded study.
Journal: The Journal of bone and joint surgery. British volume 20060801
Title: New drugs 06, part II.
Journal: Nursing 20060801
Title: Intravenous ibandronate (Boniva).
Journal: The Medical letter on drugs and therapeutics 20060801
Title: Local bioavailability and distribution of systemically (parenterally) administered ibandronate in the infarcted femoral head.
Journal: Bone 20060701
Title: Bone marker response in chronic diffuse sclerosing osteomyelitis treated with intravenous ibandronate.
Journal: Annals of the rheumatic diseases 20060701
Title: Intravenous ibandronate does not affect time to renal function deterioration in patients with skeletal metastases from breast cancer: phase III trial results.
Journal: European journal of cancer care 20060701
Title: Osseointegration of cementless implants with different bisphosphonate regimens.
Journal: Clinical orthopaedics and related research 20060601
Title: Intravenous ibandronate injections in postmenopausal women with osteoporosis: one-year results from the dosing intravenous administration study.
Journal: Arthritis and rheumatism 20060601
Title: Less frequent dosing of bisphosphonates in osteoporosis: focus on ibandronate.
Journal: Current medical research and opinion 20060601
Title: Fracture prevention in postmenopausal women.
Journal: Clinical evidence 20060601
Title: Efficacy and tolerability of once-monthly oral ibandronate in postmenopausal osteoporosis: 2 year results from the MOBILE study.
Journal: Annals of the rheumatic diseases 20060501
Title: Extracellular matrix changes in knee joint cartilage following bone-active drug treatment.
Journal: Cell and tissue research 20060501
Title: Ibandronate, an experimental intravenous bisphosphonate for osteoporosis, bone metastases, and hypercalcemia of malignancy.
Journal: Pharmacotherapy 20060501
Title: What's new in clinical pharmacology and therapeutics.
Journal: WMJ : official publication of the State Medical Society of Wisconsin 20060501
Title: Oral ibandronate in the management of postmenopausal osteoporosis: review of upper gastrointestinal safety.
Journal: Maturitas 20060420
Title: Adherence, patient preference and dosing frequency: understanding the relationship.
Journal: Bone 20060401
Title: Beyond daily dosing: clinical experience.
Journal: Bone 20060401
Title: Ibandronate: pharmacology and preclinical studies.
Journal: Bone 20060401
Title: Once-monthly dosing: an effective step forward.
Journal: Bone 20060401
Title: Preventing osteoporosis-related fractures: an overview.
Journal: The American journal of medicine 20060401
Title: Injectable drug approved for osteoporosis.
Journal: Health news (Waltham, Mass.) 20060401
Title: Once-monthly ibandronate for postmenopausal osteoporosis: review of a new dosing regimen.
Journal: Clinical therapeutics 20060401
Title: Modeling of serum C-telopeptide levels with daily and monthly oral ibandronate in humans.
Journal: Annals of the New York Academy of Sciences 20060401
Title: Drug insight: Bisphosphonates for postmenopausal osteoporosis.
Journal: Nature clinical practice. Endocrinology & metabolism 20060401
Title: Enthalpy versus entropy-driven binding of bisphosphonates to farnesyl diphosphate synthase.
Journal: Journal of the American Chemical Society 20060322
Title: [Therapy of hypercalcemia with ibandronate in case of acute renal failure].
Journal: Der Internist 20060301
Title: Ibandronate treatment for osteoporosis: rationale, preclinical, and clinical development of extended dosing regimens.
Journal: Current osteoporosis reports 20060301
Title: A new concept for bisphosphonate therapy: a rationale for the development of monthly oral dosing of ibandronate.
Journal: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20060201
Title: Independent pathways in the modulation of osteoclastic resorption by intermediates of the mevalonate biosynthetic pathway: the role of the retinoic acid receptor.
Journal: Bone 20060201
Title: Strategies for the prevention and treatment of osteoporosis during early postmenopause.
Journal: American journal of obstetrics and gynecology 20060201
Title: Rapid pain relief and remission of sternocostoclavicular hyperostosis after intravenous ibandronate therapy.
Journal: Journal of bone and mineral metabolism 20060101
Title: Additive growth inhibitory effects of ibandronate and antiestrogens in estrogen receptor-positive breast cancer cell lines.
Journal: Breast cancer research : BCR 20060101
Title: [Ibandronate once a month].
Journal: Medizinische Monatsschrift fur Pharmazeuten 20060101
Title: Ibandronic acid: a review of its use in the treatment of bone metastases of breast cancer.
Journal: Drugs 20060101
Title: Ibandronate: the evolution of a once-a-month oral therapy for postmenopausal osteoporosis.
Journal: Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry 20060101
Title: Rapid infusion of ibandronate in lung cancer patients with bone metastases.
Journal: Anticancer research 20060101
Title: Treating osteoporosis with bisphosphonates and addressing adherence: a review of oral ibandronate.
Journal: Drugs 20060101
Title: Sequence- and concentration-dependent effects of acute and long-term exposure to the bisphosphonate ibandronate in combination with single and multiple fractions of ionising radiation doses in human breast cancer cell lines.
Journal: Clinical & experimental metastasis 20060101
Title: Intravenous ibandronate: in the treatment of osteoporosis.
Journal: Drugs 20060101
Title: Ibandronate: its role in metastatic breast cancer.
Journal: The oncologist 20060101
Title: Ibandronate for the treatment of hypercalcemia or nephrocalcinosis in patients with multiple myeloma and acute renal failure: Case reports.
Journal: Acta haematologica 20060101
Title: Non-ulcerating calcific uremic arteriolopathy skin lesion treated successfully with intravenous ibandronate.
Journal: Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis 20060101
Title: Tolerability of different dosing regimens of bisphosphonates for the treatment of osteoporosis and malignant bone disease.
Journal: Drug safety 20060101
Title: Intravenous ibandronate in the treatment of osteoporosis: profile report.
Journal: Drugs & aging 20060101
Title: Safety of oral ibandronate in the treatment of bone metastases from breast cancer : long-term follow-up experience.
Journal: Clinical drug investigation 20060101
Title: Long-term safety of intravenous ibandronic acid for up to 4 years in metastatic breast cancer: an open-label trial.
Journal: Clinical drug investigation 20060101
Title: [The role of ibandronate in the daily oncological practice].
Journal: Magyar onkologia 20060101
Title: [Ibandronate].
Journal: Reumatizam 20060101
Title: Cost-effectiveness of oral ibandronate compared with intravenous (i.v.) zoledronic acid or i.v. generic pamidronate in breast cancer patients with metastatic bone disease undergoing i.v. chemotherapy.
Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 20051201
Title: Effective and rapid treatment of painful localized transient osteoporosis (bone marrow edema) with intravenous ibandronate.
Journal: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20051201
Title: Does avascular necrosis of the jaws in cancer patients only occur following treatment with bisphosphonates?
Journal: Journal of cranio-maxillo-facial surgery : official publication of the European Association for Cranio-Maxillo-Facial Surgery 20051201
Title: Newer drug treatments: their effects on fracture prevention.
Journal: Best practice & research. Clinical rheumatology 20051201
Title: Acute renal effects of intravenous bisphosphonates in the rat.
Journal: Basic & clinical pharmacology & toxicology 20051201
Title: Patient preference for once-monthly ibandronate versus once-weekly alendronate in a randomized, open-label, cross-over trial: the Boniva Alendronate Trial in Osteoporosis (BALTO).
Journal: Current medical research and opinion 20051201
Title: Highlights From ECCO 13-The European Cancer Conference Paris, France October 30 to November 3, 2005.
Journal: Clinical breast cancer 20051201
Title: Oral ibandronate significantly reduces the risk of vertebral fractures of greater severity after 1, 2, and 3 years in postmenopausal women with osteoporosis.
Journal: Bone 20051101
Title: High dosage treatment of nitrogen-containing bisphosphonate ibandronate is required for osseointegration of cementless metal implants.
Journal: Journal of orthopaedic science : official journal of the Japanese Orthopaedic Association 20051101
Title: S0307. Phase III trial of bisphosphonates as adjuvant therapy for primary breast cancer.
Journal: Clinical advances in hematology & oncology : H&O 20051101
Title: Biological properties and mechanism of action of ibandronate: application to the treatment of osteoporosis.
Journal: Bone 20051001
Title: Safety and tolerability of oral daily and intermittent ibandronate are not influenced by age.
Journal: The Journal of rheumatology 20051001
Title: Oral ibandronate: a less frequently administered therapeutic option for postmenopausal osteoporosis.
Journal: Expert opinion on pharmacotherapy 20051001
Title: Review of treatment modalities for postmenopausal osteoporosis.
Journal: Southern medical journal 20051001
Title: Ibandronate: efficacy in the treatment of metastatic bone disease.
Journal: Future oncology (London, England) 20051001
Title: Analytical methods for the quantification of ibandronate in body fluids and bone.
Journal: Journal of pharmaceutical and biomedical analysis 20050901
Title: Monthly oral ibandronate is well tolerated and efficacious in postmenopausal women: results from the monthly oral pilot study.
Journal: The Journal of clinical endocrinology and metabolism 20050901
Title: The bisphosphonate ibandronate improves implant integration in osteopenic ovariectomized rats.
Journal: Bone 20050801
Title: Monthly oral ibandronate therapy in postmenopausal osteoporosis: 1-year results from the MOBILE study.
Journal: Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20050801
Title: Ibandronate (Boniva): a new oral bisphosphonate.
Journal: Obstetrics and gynecology 20050801
Title: Cost-effectiveness of oral ibandronate versus IV zoledronic acid or IV pamidronate for bone metastases in patients receiving oral hormonal therapy for breast cancer in the United Kingdom.
Journal: Clinical therapeutics 20050801
Title: A new option for osteoporosis.
Journal: The Johns Hopkins medical letter health after 50 20050701
Title: New therapeutic agents for the treatment of bone diseases.
Journal: Expert opinion on biological therapy 20050601
Title: Efficacy and safety of intravenous bisphosphonates for patients with breast cancer metastatic to bone: a review of randomized, double-blind, phase III trials.
Journal: Clinical breast cancer 20050601
Title: First once-a-month osteoporosis pill approved.
Journal: Harvard women's health watch 20050601
Title: A bright future for osteoporosis treatment.
Journal: Drug news & perspectives 20050601
Title: Longer-lasting osteoporosis drugs sought.
Journal: JAMA 20050525
Title: Bisphosphonates in breast cancer.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology 20050501
Title: Changes in bone structure after augmentation cystoplasty in chronic uraemic rats.
Journal: BJU international 20050501
Title: The issue of renal safety of zoledronic acid from a nephrologist's point of view.
Journal: The oncologist 20050501
Title: 'Safety and convenience of a 15-minute infusion of zoledronic acid': not so safe.
Journal: The oncologist 20050501
Title: New drugs and dosage forms.
Journal: American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20050501
Title: Ibandronate (Boniva): a new oral bisphosphonate.
Journal: The Medical letter on drugs and therapeutics 20050425
Title: Oral ibandronate for the treatment of metastatic bone disease in breast cancer: efficacy and safety results from a randomized, double-blind, placebo-controlled trial.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology 20050301
Title: Ibandronate for prevention of femoral head deformity after ischemic necrosis of the capital femoral epiphysis in immature pigs.
Journal: The Journal of bone and joint surgery. American volume 20050301
Title: Oral antiresorptive therapy.
Journal: Current rheumatology reports 20050301
Title: Rapid prevention of vertebral fractures associated with osteoporosis.
Journal: Orthopedics 20050301
Title: Ibandronate produces significant, similar antifracture efficacy in North American and European women: new clinical findings from BONE.
Journal: Current medical research and opinion 20050301
Title: Effective doses of ibandronate do not influence the 3-year progression of aortic calcification in elderly osteoporotic women.
Journal: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20050201
Title: Explicit solutions for a class of indirect pharmacodynamic response models.
Journal: Computer methods and programs in biomedicine 20050201
Title: Ibandronate in metastatic bone disease: a review of preclinical data.
Journal: Anti-cancer drugs 20050201
Title: Oral ibandronic acid.
Journal: IDrugs : the investigational drugs journal 20050201
Title: [Ibandronate as a new therapeutic agent for osteoporosis].
Journal: Clinical calcium 20050101
Title: The role of bisphosphonates in the management of advanced cancer with a focus on non-small-cell lung cancer. Part 1: Mechanisms of action, role of biomarkers and preclinical applications.
Journal: Oncology 20050101
Title: Clinical pharmacology of potent new bisphosphonates for postmenopausal osteoporosis.
Journal: Treatments in endocrinology 20050101
Title: [Monthly tablet].
Journal: Krankenpflege Journal 20050101
Title: New drugs: entecavir, ibandronate sodium, and pegaptanib sodium.
Journal: Journal of the American Pharmacists Association : JAPhA 20050101
Title: Optimizing administration of bisphosphonates in women with postmenopausal osteoporosis.
Journal: Treatments in endocrinology 20050101
Title: Bisphosphonate treatment does not affect serum levels of osteoprotegerin and RANKL in hypercalcemic cancer patients.
Journal: Anticancer research 20050101
Title: [Postmenopausal osteoporosis].
Journal: Krankenpflege Journal 20050101
Title: Efficacy of ibandronate in metastatic bone disease: review of clinical data.
Journal: The oncologist 20050101
Title: Renal safety of ibandronate.
Journal: The oncologist 20050101
Title: Oral and intravenous ibandronate in the management of postmenopausal osteoporosis: a comprehensive review.
Journal: Current pharmaceutical design 20050101
Title: Once-monthly ibandronate.
Journal: Treatments in endocrinology 20050101
Title: High bone-binding capacity of ibandronate in hemodialysis patients.
Journal: International journal of clinical pharmacology research 20050101
Title: [Zoledronic acid and bone pathology in the course of neoplasia. Part I].
Journal: Tumori 20050101
Title: [Monthly tablet in postmenopausal osteoporosis].
Journal: Krankenpflege Journal 20050101
Title: Rapid administration of ibandronate does not affect renal functioning: evidence from clinical studies in metastatic bone disease and hypercalcaemia of malignancy.
Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 20041201
Title: A semimechanistic and mechanistic population PK-PD model for biomarker response to ibandronate, a new bisphosphonate for the treatment of osteoporosis.
Journal: British journal of clinical pharmacology 20041201
Title: Ibandronate: its pharmacology and clinical efficacy in the management of tumor-induced hypercalcemia and metastatic bone disease.
Journal: Expert review of anticancer therapy 20041201
Title: Optimizing bisphosphonate therapy in patients with breast cancer on endocrine therapy.
Journal: Seminars in oncology 20041201
Title: [Clinical trial on ibandronate in patients with tumor-associated hypercalcemia].
Journal: Zhonghua zhong liu za zhi [Chinese journal of oncology] 20041201
Title: Review of ibandronate in the treatment of metastatic bone disease: experience from phase III trials.
Journal: Clinical therapeutics 20041201
Title: Intermittent ibandronate preserves bone quality and bone strength in the lumbar spine after 16 months of treatment in the ovariectomized cynomolgus monkey.
Journal: Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20041101
Title: Breast tumour growth inhibition in vitro through the combination of cyclophosphamide/metotrexate/5-fluorouracil, epirubicin/cyclophosphamide, epirubicin/paclitaxel, and epirubicin/docetaxel with the bisphosphonates ibandronate and zoledronic acid.
Journal: Oncology reports 20041101
Title: Efficacy and safety of ibandronate in the treatment of neoplastic bone disease.
Journal: Expert opinion on pharmacotherapy 20041101
Title: Daily and intermittent oral ibandronate normalize bone turnover and provide significant reduction in vertebral fracture risk: results from the BONE study.
Journal: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20041001
Title: Oral ibandronate improves bone pain and preserves quality of life in patients with skeletal metastases due to breast cancer.
Journal: Pain 20041001
Title: The efficacy and safety of oral ibandronate in the treatment of metastatic bone disease in patients with breast cancer.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology 20041001
Title: Targeting Breast Cancer with Care. Proceedings of a meeting. Prague, Czech Republic, February 2004.
Journal: Seminars in oncology 20041001
Title: Ibandronate reduces skeletal morbidity in patients with breast cancer.
Journal: Seminars in oncology 20041001
Title: Ibandronate in metastatic bone pain.
Journal: Seminars in oncology 20041001
Title: Managing metastatic bone disease: three case studies.
Journal: Seminars in oncology 20041001
Title: The RIB trial.
Journal: Clinical oncology (Royal College of Radiologists (Great Britain)) 20041001
Title: Systemic and local ibandronate enhance screw fixation.
Journal: Journal of orthopaedic research : official publication of the Orthopaedic Research Society 20040901
Title: Ibandronate: a clinical pharmacological and pharmacokinetic update.
Journal: Journal of clinical pharmacology 20040901
Title: Efficacy and safety of ibandronate in the treatment of opioid-resistant bone pain associated with metastatic bone disease: a pilot study.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20040901
Title: [Therapy of painful bone metastases in patients with prostate carcinoma. The AP 32/02 Study of the AUO].
Journal: Der Urologe. Ausg. A 20040901
Title: In vitro toxicity of bisphosphonates on human neuroblastoma cell lines.
Journal: Anti-cancer drugs 20040901
Title: Effects of oral ibandronate administered daily or intermittently on fracture risk in postmenopausal osteoporosis.
Journal: Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20040801
Title: Comparative responses of bone turnover markers to bisphosphonate therapy in Paget's disease of bone.
Journal: Bone 20040701
Title: Improved quality of life after long-term treatment with the bisphosphonate ibandronate in patients with metastatic bone disease due to breast cancer.
Journal: European journal of cancer (Oxford, England : 1990) 20040701
Title: Ibandronate in osteoporosis: preclinical data and rationale for intermittent dosing.
Journal: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20040601
Title: Decreased levels of osteopontin and bone sialoprotein II are correlated with reduced proliferation, colony formation, and migration of GFP-MDA-MB-231 cells.
Journal: International journal of oncology 20040501
Title: Treatment of idiopathic hyperphosphatasia with intensive bisphosphonate therapy.
Journal: Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20040501
Title: Ibandronate and prevention of postmenopausal osteoporosis.
Journal: Annals of the rheumatic diseases 20040501
Title: Bisphosphonates and reduction of skeletal events in patients with bone metastatic breast cancer.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology 20040501
Title: Oral ibandronate for the treatment of metastatic bone disease in breast cancer: efficacy and safety results from a randomized, double-blind, placebo-controlled trial.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology 20040501
Title: Efficacy and safety of ibandronate given by intravenous injection once every 3 months.
Journal: Bone 20040501
Title: Insufficiently dosed intravenous ibandronate injections are associated with suboptimal antifracture efficacy in postmenopausal osteoporosis.
Journal: Bone 20040501
Title: [Bone metastases in breast carcinoma. Bisphosphonate protects from complications].
Journal: MMW Fortschritte der Medizin 20040401
Title: Oral ibandronate reduces the risk of skeletal complications in breast cancer patients with metastatic bone disease: results from two randomised, placebo-controlled phase III studies.
Journal: British journal of cancer 20040322
Title: Histomorphometric evaluation of daily and intermittent oral ibandronate in women with postmenopausal osteoporosis: results from the BONE study.
Journal: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20040301
Title: Intravenous ibandronate reduces the incidence of skeletal complications in patients with breast cancer and bone metastases.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology 20040301
Title: Nephrotoxicity of third-generation, intravenous bisphosphonates.
Journal: Toxicology 20040301
Title: [Ibandronate].
Journal: Nihon rinsho. Japanese journal of clinical medicine 20040201
Title: Serum levels of the fetuin-mineral complex correlate with artery calcification in the rat.
Journal: The Journal of biological chemistry 20040116
Title: Oral daily ibandronate prevents bone loss in early postmenopausal women without osteoporosis.
Journal: Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20040101
Title: Safety and convenience of a 15-minute infusion of zoledronic acid.
Journal: The oncologist 20040101
Title: New model for simulation of fracture repair in full-grown beagle dogs: model characterization and results from a long-term study with ibandronate.
Journal: Journal of pharmacological and toxicological methods 20040101
Title: [Ibandronate: keep life in motion].
Journal: Tumori 20040101
Title: [Oral and parenteral forms of aminobisphosphonate].
Journal: Krankenpflege Journal 20040101
Title: [AIOM Conference 2004. Endocrine therapy and management of patients with bone metastasis of breast cancer].
Journal: Tumori 20040101
Title: [ESMO Conference 2004. Ibandronate in the treatment of bone metastasis].
Journal: Tumori 20040101
Title: Ibandronate improves hyperphosphatemia in dialysis patients with hyperparathyroidism.
Journal: International urology and nephrology 20040101
Title: Injectable drug dampens bone loss.
Journal: Health news (Waltham, Mass.) 20031201
Title: Is ibandronate effective in multiple myeloma?
Journal: European journal of haematology 20031201
Title: Use of highly potent bisphosphonates in the treatment of osteoporosis.
Journal: Current osteoporosis reports 20031201
Title: Bisphosphonates in children with bone diseases.
Journal: The New England journal of medicine 20031120
Title: Site-specific human breast cancer (MDA-MB-231) metastases in nude rats: model characterisation and in vivo effects of ibandronate on tumour growth.
Journal: International journal of cancer 20031110
Title: Ibandronate: new options in the treatment of osteoporosis.
Journal: Drugs of today (Barcelona, Spain : 1998) 20031101
Title: Intravenous ibandronate injections given every three months: a new treatment option to prevent bone loss in postmenopausal women.
Journal: Annals of the rheumatic diseases 20031001
Title: The effects of three-month intravenous ibandronate on bone mineral density and bone remodeling in Klinefelter's syndrome: the influence of vitamin D deficiency and hormonal status.
Journal: Bone 20031001
Title: Efficacy and safety of oral weekly ibandronate in the treatment of postmenopausal osteoporosis.
Journal: The Journal of clinical endocrinology and metabolism 20031001
Title: Intermittent intravenous ibandronate injections reduce vertebral fracture risk in corticosteroid-induced osteoporosis: results from a long-term comparative study.
Journal: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20031001
Title: The renal effects of minimally nephrotoxic doses of ibandronate and zoledronate following single and intermittent intravenous administration in rats.
Journal: Toxicology 20030930
Title: Intravenous ibandronate reduces the incidence of skeletal complications in patients with breast cancer and bone metastases.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology 20030901
Title: Efficacy and safety of ibandronate in the treatment of hypercalcemia of malignancy: a randomized multicentric comparison to pamidronate.
Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 20030801
Title: Oral weekly ibandronate prevents bone loss in postmenopausal women.
Journal: Journal of internal medicine 20030801
Title: Injectable bisphosphonates in the treatment of postmenopausal osteoporosis.
Journal: Aging clinical and experimental research 20030801
Title: Intravenous ibandronate in men with osteoporosis: an open pilot study over 2 years.
Journal: Journal of endocrinological investigation 20030801
Title: The bisphosphonate ibandronate stimulates reverse cholesterol transport out of monocytoid cells by enhanced ABCA1 transcription.
Journal: Biochemical and biophysical research communications 20030718
Title: Dose dependent effects on bone resorption and formation of intermittently administered intravenous ibandronate.
Journal: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20030701
Title: Lytic bone lesions in human neuroblastoma xenograft involve osteoclast recruitment and are inhibited by bisphosphonate.
Journal: Cancer research 20030615
Title: Three-monthly ibandronate bolus injection offers favourable tolerability and sustained efficacy advantage over two years in established corticosteroid-induced osteoporosis.
Journal: Rheumatology (Oxford, England) 20030601
Title: Oral ibandronate: changes in markers of bone turnover during adequately dosed continuous and weekly therapy and during different suboptimally dosed treatment regimens.
Journal: Bone 20030601
Title: Ibandronate: a potent new bisphosphonate in the management of postmenopausal osteoporosis.
Journal: International journal of clinical practice 20030601
Title: Effects of ibandronate on inflammation in mouse antigen-induced arthritis.
Journal: Inflammation research : official journal of the European Histamine Research Society ... [et al.] 20030501
Title: The efficacy of 48-week oral ibandronate treatment in postmenopausal osteoporosis when taken 30 versus 60 minutes before breakfast.
Journal: Bone 20030401
Title: Therapy of osteoporosis in patients with Crohn's disease: a randomized study comparing sodium fluoride and ibandronate.
Journal: Alimentary pharmacology & therapeutics 20030315
Title: Review of ibandronate in the treatment of osteoporosis.
Journal: Expert opinion on pharmacotherapy 20030301
Title: Antagonistic effects of different classes of bisphosphonates in osteoclasts and macrophages in vitro.
Journal: Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20030201
Title: Intermittent intravenous administration of the bisphosphonate ibandronate prevents bone loss and maintains bone strength and quality in ovariectomized cynomolgus monkeys.
Journal: Bone 20030101
Title: Pamidronate is superior to ibandronate in decreasing bone resorption, interleukin-6 and beta 2-microglobulin in multiple myeloma.
Journal: European journal of haematology 20030101
Title: Effect of daily and intermittent use of ibandronate on bone mass and bone turnover in postmenopausal osteoporosis: a review of three phase II studies.
Journal: Clinical therapeutics 20030101
Title: Bisphosphonates in the management of metastatic prostate cancer.
Journal: Oncology 20030101
Title: [Effects of ibandronate on the osteopenia process in tail-suspended rats].
Journal: Aviakosmicheskaia i ekologicheskaia meditsina = Aerospace and environmental medicine 20030101
Title: Treatment of hypercalcemia of malignancy with bisphosphonates.
Journal: Seminars in oncology 20021201
Title: Bisphosphonates inhibit angiogenesis in vitro and testosterone-stimulated vascular regrowth in the ventral prostate in castrated rats.
Journal: Cancer research 20021115
Title: The amino bisphosphonate ibandronate prevents calciphylaxis in the rat at doses that inhibit bone resorption.
Journal: Calcified tissue international 20021001
Title: The effect of the bisphosphonate ibandronate on breast cancer metastasis to visceral organs.
Journal: Breast cancer research and treatment 20021001
Title: Effects of treatment with ibandronate on bone mass, architecture, biomechanical properties, and bone concentration of ibandronate in ovariectomized aged rats.
Journal: The Journal of rheumatology 20021001
Title: Effect of transplantation on bone: osteoporosis after liver and multivisceral transplantation.
Journal: Transplantation proceedings 20020901
Title: Elimination of intravenously administered ibandronate in patients on haemodialysis: a monocentre open study.
Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20020701
Title: Novel therapeutic options for osteoporosis.
Journal: Current opinion in rheumatology 20020701
Title: Effect of bisphosphonates on cartilage turnover assessed with a newly developed assay for collagen type II degradation products.
Journal: Annals of the rheumatic diseases 20020601
Title: Bisphosphonates influence the proliferation and the maturation of normal human osteoblasts.
Journal: Journal of endocrinological investigation 20020601
Title: Effects of long-term intravenous ibandronate therapy on skeletal-related events, survival, and bone resorption markers in patients with advanced multiple myeloma.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20020501
Title: Total administered dose of ibandronate determines its effects on bone mass and architecture in ovariectomized aged rats.
Journal: The Journal of rheumatology 20020501
Title: Bisphosphonates for prevention of postmenopausal osteoporosis.
Journal: Danish medical bulletin 20020201
Title: Ibandronate treatment decreases the effects of tumor-associated lesions on bone density and strength in the rat.
Journal: Bone 20020101
Title: Association between pharmacokinetics of oral ibandronate and clinical response in bone mass and bone turnover in women with postmenopausal osteoporosis.
Journal: Bone 20020101
Title: Safety and efficacy of the new bisphosphonate ibandronate in the management of bone metastasis following rapid infusion.
Journal: In vivo (Athens, Greece) 20020101
Title: Ibandronate in the treatment of prostate cancer associated painful osseous metastases.
Journal: Prostate cancer and prostatic diseases 20020101
Title: Ibandronate: a comparison of oral daily dosing versus intermittent dosing in postmenopausal osteoporosis.
Journal: Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20011001
Title: [Radiotherapy and bisphosphonate therapy in bone metastases of prostate carcinoma].
Journal: Praxis 20010920
Title: Effect of ibandronate on bone loss and renal function after kidney transplantation.
Journal: Journal of the American Society of Nephrology : JASN 20010701
Title: The bisphosphonate ibandronate promotes apoptosis in MDA-MB-231 human breast cancer cells in bone metastases.
Journal: Cancer research 20010601
Title: Bisphosphonates alendronate and ibandronate inhibit artery calcification at doses comparable to those that inhibit bone resorption.
Journal: Arteriosclerosis, thrombosis, and vascular biology 20010501
Title: Ibandronate decreases bone disease development and osteoclast stimulatory activity in an in vivo model of human myeloma.
Journal: Experimental hematology 20010401
Title: Bisphosphonates induce breast cancer cell death in vitro.
Journal: Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20001101
Title: Nitrogen-containing bisphosphonates inhibit the mevalonate pathway and prevent post-translational prenylation of GTP-binding proteins, including Ras.
Journal: Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 19980401
Title: Morgan, C., S. Jeremiah, and J. Wagstaff, Metronomic administration of ibandronate and its anti-angiogenic effects in vitro. Microvasc Res, 2009. 78(3): p. 453-8.
Title: Epplen, R., et al., Differential effects of ibandronate, docetaxel and farnesol treatment alone and in combination on the growth of prostate cancer cell lines. Acta Oncol, 2011. 50(1): p. 127-33.
Title: Chesnut, I.C., et al., Effects of oral ibandronate administered daily or intermittently on fracture risk in postmenopausal osteoporosis. J Bone Miner Res, 2004. 19(8): p. 1241-9.
Title: Bauss, F., et al., Effects of treatment with ibandronate on bone mass, architecture, biomechanical properties, and bone concentration of ibandronate in ovariectomized aged rats. J Rheumatol, 2002. 29(10): p. 2200-8.
